Global Lipid Nanoparticles (LNP) Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI01240018

Publication Date:

January 11, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Lipid Nanoparticles (LNP) market size was valued at US$ 570.5 million in 2023. With growing demand in downstream market, the Lipid Nanoparticles (LNP) is forecast to a readjusted size of US$ 951 million by 2030 with a CAGR of 7.6% during review period.
The research report highlights the growth potential of the global Lipid Nanoparticles (LNP) market. Lipid Nanoparticles (LNP) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Lipid Nanoparticles (LNP). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Lipid Nanoparticles (LNP) market.
LNPs are liposome-like structures especially geared towards encapsulating a broad variety of nucleic acids (RNA and DNA); and as such, they are the most popular non-viral gene delivery system. Exelead develops and manufactures LNPs to encapsulate different types of genetic payloads including siRNA, mRNA and saRNA.
The world's core manufacturers of Lipid Nanoparticles include Merck KGaA and others. The largest manufacturer has approximately 70% of the market share. North America is the world's largest market, accounting for approximately 60% of the market, followed by Europe and Asia Pacific, accounting for 26% and 9%, respectively. Among them, mRNA-lipid nanoparticles and siRNA-lipid nanoparticles accounted for 93% and 5%, respectively. The most used are vaccine drugs and scientific research, accounting for 81% and 19% respectively.
Key Features:
The report on Lipid Nanoparticles (LNP) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Lipid Nanoparticles (LNP) market. It may include historical data, market segmentation by Type (e.g., mRNA-lipid Nanoparticle, siRNA-lipid Nanoparticle), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Lipid Nanoparticles (LNP) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Lipid Nanoparticles (LNP) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Lipid Nanoparticles (LNP) industry. This include advancements in Lipid Nanoparticles (LNP) technology, Lipid Nanoparticles (LNP) new entrants, Lipid Nanoparticles (LNP) new investment, and other innovations that are shaping the future of Lipid Nanoparticles (LNP).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Lipid Nanoparticles (LNP) market. It includes factors influencing customer ' purchasing decisions, preferences for Lipid Nanoparticles (LNP) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Lipid Nanoparticles (LNP) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Lipid Nanoparticles (LNP) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Lipid Nanoparticles (LNP) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Lipid Nanoparticles (LNP) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Lipid Nanoparticles (LNP) market.
Market Segmentation:
Lipid Nanoparticles (LNP) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
mRNA-lipid Nanoparticle
siRNA-lipid Nanoparticle
Others
Segmentation by application
Vaccines and Drugs
Scientific Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Precision NanoSystems
Evonik
Merck KGaA
Genevant Sciences
Exelead
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lipid Nanoparticles (LNP) Market Size 2019-2030
2.1.2 Lipid Nanoparticles (LNP) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Lipid Nanoparticles (LNP) Segment by Type
2.2.1 mRNA-lipid Nanoparticle
2.2.2 siRNA-lipid Nanoparticle
2.2.3 Others
2.3 Lipid Nanoparticles (LNP) Market Size by Type
2.3.1 Lipid Nanoparticles (LNP) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Lipid Nanoparticles (LNP) Market Size Market Share by Type (2019-2024)
2.4 Lipid Nanoparticles (LNP) Segment by Application
2.4.1 Vaccines and Drugs
2.4.2 Scientific Research
2.5 Lipid Nanoparticles (LNP) Market Size by Application
2.5.1 Lipid Nanoparticles (LNP) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Lipid Nanoparticles (LNP) Market Size Market Share by Application (2019-2024)
3 Lipid Nanoparticles (LNP) Market Size by Player
3.1 Lipid Nanoparticles (LNP) Market Size Market Share by Players
3.1.1 Global Lipid Nanoparticles (LNP) Revenue by Players (2019-2024)
3.1.2 Global Lipid Nanoparticles (LNP) Revenue Market Share by Players (2019-2024)
3.2 Global Lipid Nanoparticles (LNP) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Lipid Nanoparticles (LNP) by Regions
4.1 Lipid Nanoparticles (LNP) Market Size by Regions (2019-2024)
4.2 Americas Lipid Nanoparticles (LNP) Market Size Growth (2019-2024)
4.3 APAC Lipid Nanoparticles (LNP) Market Size Growth (2019-2024)
4.4 Europe Lipid Nanoparticles (LNP) Market Size Growth (2019-2024)
4.5 Middle East & Africa Lipid Nanoparticles (LNP) Market Size Growth (2019-2024)
5 Americas
5.1 Americas Lipid Nanoparticles (LNP) Market Size by Country (2019-2024)
5.2 Americas Lipid Nanoparticles (LNP) Market Size by Type (2019-2024)
5.3 Americas Lipid Nanoparticles (LNP) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lipid Nanoparticles (LNP) Market Size by Region (2019-2024)
6.2 APAC Lipid Nanoparticles (LNP) Market Size by Type (2019-2024)
6.3 APAC Lipid Nanoparticles (LNP) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Lipid Nanoparticles (LNP) by Country (2019-2024)
7.2 Europe Lipid Nanoparticles (LNP) Market Size by Type (2019-2024)
7.3 Europe Lipid Nanoparticles (LNP) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lipid Nanoparticles (LNP) by Region (2019-2024)
8.2 Middle East & Africa Lipid Nanoparticles (LNP) Market Size by Type (2019-2024)
8.3 Middle East & Africa Lipid Nanoparticles (LNP) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Lipid Nanoparticles (LNP) Market Forecast
10.1 Global Lipid Nanoparticles (LNP) Forecast by Regions (2025-2030)
10.1.1 Global Lipid Nanoparticles (LNP) Forecast by Regions (2025-2030)
10.1.2 Americas Lipid Nanoparticles (LNP) Forecast
10.1.3 APAC Lipid Nanoparticles (LNP) Forecast
10.1.4 Europe Lipid Nanoparticles (LNP) Forecast
10.1.5 Middle East & Africa Lipid Nanoparticles (LNP) Forecast
10.2 Americas Lipid Nanoparticles (LNP) Forecast by Country (2025-2030)
10.2.1 United States Lipid Nanoparticles (LNP) Market Forecast
10.2.2 Canada Lipid Nanoparticles (LNP) Market Forecast
10.2.3 Mexico Lipid Nanoparticles (LNP) Market Forecast
10.2.4 Brazil Lipid Nanoparticles (LNP) Market Forecast
10.3 APAC Lipid Nanoparticles (LNP) Forecast by Region (2025-2030)
10.3.1 China Lipid Nanoparticles (LNP) Market Forecast
10.3.2 Japan Lipid Nanoparticles (LNP) Market Forecast
10.3.3 Korea Lipid Nanoparticles (LNP) Market Forecast
10.3.4 Southeast Asia Lipid Nanoparticles (LNP) Market Forecast
10.3.5 India Lipid Nanoparticles (LNP) Market Forecast
10.3.6 Australia Lipid Nanoparticles (LNP) Market Forecast
10.4 Europe Lipid Nanoparticles (LNP) Forecast by Country (2025-2030)
10.4.1 Germany Lipid Nanoparticles (LNP) Market Forecast
10.4.2 France Lipid Nanoparticles (LNP) Market Forecast
10.4.3 UK Lipid Nanoparticles (LNP) Market Forecast
10.4.4 Italy Lipid Nanoparticles (LNP) Market Forecast
10.4.5 Russia Lipid Nanoparticles (LNP) Market Forecast
10.5 Middle East & Africa Lipid Nanoparticles (LNP) Forecast by Region (2025-2030)
10.5.1 Egypt Lipid Nanoparticles (LNP) Market Forecast
10.5.2 South Africa Lipid Nanoparticles (LNP) Market Forecast
10.5.3 Israel Lipid Nanoparticles (LNP) Market Forecast
10.5.4 Turkey Lipid Nanoparticles (LNP) Market Forecast
10.5.5 GCC Countries Lipid Nanoparticles (LNP) Market Forecast
10.6 Global Lipid Nanoparticles (LNP) Forecast by Type (2025-2030)
10.7 Global Lipid Nanoparticles (LNP) Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Precision NanoSystems
11.1.1 Precision NanoSystems Company Information
11.1.2 Precision NanoSystems Lipid Nanoparticles (LNP) Product Offered
11.1.3 Precision NanoSystems Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Precision NanoSystems Main Business Overview
11.1.5 Precision NanoSystems Latest Developments
11.2 Evonik
11.2.1 Evonik Company Information
11.2.2 Evonik Lipid Nanoparticles (LNP) Product Offered
11.2.3 Evonik Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Evonik Main Business Overview
11.2.5 Evonik Latest Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Company Information
11.3.2 Merck KGaA Lipid Nanoparticles (LNP) Product Offered
11.3.3 Merck KGaA Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Merck KGaA Main Business Overview
11.3.5 Merck KGaA Latest Developments
11.4 Genevant Sciences
11.4.1 Genevant Sciences Company Information
11.4.2 Genevant Sciences Lipid Nanoparticles (LNP) Product Offered
11.4.3 Genevant Sciences Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Genevant Sciences Main Business Overview
11.4.5 Genevant Sciences Latest Developments
11.5 Exelead
11.5.1 Exelead Company Information
11.5.2 Exelead Lipid Nanoparticles (LNP) Product Offered
11.5.3 Exelead Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Exelead Main Business Overview
11.5.5 Exelead Latest Developments
11.6 Avanti Polar Lipids
11.6.1 Avanti Polar Lipids Company Information
11.6.2 Avanti Polar Lipids Lipid Nanoparticles (LNP) Product Offered
11.6.3 Avanti Polar Lipids Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Avanti Polar Lipids Main Business Overview
11.6.5 Avanti Polar Lipids Latest Developments
11.7 Nippon Fine Chemical
11.7.1 Nippon Fine Chemical Company Information
11.7.2 Nippon Fine Chemical Lipid Nanoparticles (LNP) Product Offered
11.7.3 Nippon Fine Chemical Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Nippon Fine Chemical Main Business Overview
11.7.5 Nippon Fine Chemical Latest Developments
11.8 Lipoid
11.8.1 Lipoid Company Information
11.8.2 Lipoid Lipid Nanoparticles (LNP) Product Offered
11.8.3 Lipoid Lipid Nanoparticles (LNP) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Lipoid Main Business Overview
11.8.5 Lipoid Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂